[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596302":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":43,"responsibleParty":63,"collaborators":25,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":25,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":25,"enrollmentInfo":75,"targetDuration":25,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":86,"overallStatus":46,"whyStopped":25,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"University Medical Centre Ljubljana","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm 1: Cerebrolysin Group","EXPERIMENTAL","The patients in Arm 1 will be treated with cerebrolysin and standard treatment.",[13,14],"Drug: Cerebrolysin treatment","Other: Standard treatment (including neurorehabilitation) of acute ischemic stroke",{"label":16,"type":6,"description":17,"interventionNames":18},"Arm 2: Standard treatment only Group","The patients in Arm 2 will receive standard treatment only.",[14],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Cerebrolysin treatment","The patients will receive Cerebrolysin treatment, 10 days consecutively, 30 ml\u002Fday, intravenous infusion diluted up to 100 ml of 0.9% saline in 15 minutes.",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Standard treatment (including neurorehabilitation) of acute ischemic stroke","\"Standard treatment\" entails acute ischemic stroke reperfusion treatment according to international guidelines and local policies, instituting secondary preventive treatment, a proper management of stroke risk factors and neurorehabilitation according to patient's needs: locomotor physiotherapy, occupation therapy, speech therapy, and neuropsychological assessment.",[9,16],[31],{"name":32,"affiliation":5,"role":33},"Matija Zupan, MD, PhD","PRINCIPAL_INVESTIGATOR",[35,39],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","0038615229581","matija.zupan@kclj.si",{"name":40,"role":36,"phone":41,"phoneExt":25,"email":42},"Marjan Zaletel, MD, PhD","0038615227115","marjan.zaletel@kclj.si",[44],{"facility":45,"status":46,"city":47,"state":25,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT)","RECRUITING","Ljubljana","1000","Slovenia","SI",{"type":52,"coordinates":53},"Point",[54,55],14.50513,46.05108,{"lat":55,"lon":54},[58,59,60,61],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},{"name":40,"role":36,"phone":41,"phoneExt":25,"email":42},{"name":32,"role":33,"phone":25,"phoneExt":25,"email":25},{"name":40,"role":62,"phone":25,"phoneExt":25,"email":25},"SUB_INVESTIGATOR",{"type":33,"investigatorFullName":64,"investigatorTitle":65,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Matija Zupan","neurologist, MD, PhD","100596302","cerebrolysin-in-early-stroke-rehabilitation---tertiary-study-100596302",false,"NCT07043686","Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study","Effect of Cerebrolysin on Early Rehabilitation After Ischemic Stroke at the Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT), University Medical Centre Ljubljana","Inclusion Criteria:\n\nBeing able to perform ARAT test Signed informed consent\n\nBoth sexes, age not specified\n\nAcute ischemic stroke confirmed by imaging\n\nNIHSS score 6-12\n\nNo prior stroke or disability (mRS 0 before stroke)\n\n\\-\n\nExclusion Criteria:\n\nNot being able to perform ARAT test\n\n* Previous stroke or disability (mRS \\> 0)\n* The patient unable to understand instructions","ALL","18 Years",{"count":76,"type":77},30,"ESTIMATED","INTERVENTIONAL",[80],"NA","The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.",[83,84,85],"Ischemic Stroke, Acute","Rehabilitation Outcome","Cerebrolysin",[85,87,88,89,90,49],"Acute Ischemic Stroke","Neuroplasticity","Neurorehabilitation","Action Research Arm Test","2025-07-03",{"date":93,"type":94},"2025-07-09","ACTUAL",{"date":96,"type":94},"2025-06-13",{"date":98,"type":77},"2027-10-15",{"name":5,"class":6},1]